seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LungCanSeek
    • OncoGate
    • LeukoPrint
    • OncoGraph
    • PanCanSeek
    • SeekInEZ
    • EGFRseek
    • PHLseek
    • SeekInJoy
    • PetCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LungCanSeek
      • OncoGate
      • LeukoPrint
      • OncoGraph
      • PanCanSeek
      • SeekInEZ
      • EGFRseek
      • PHLseek
      • SeekInJoy
      • PetCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry

seek and you will find

  • Home
  • Technology
  • Products 
    • Products Overview
    • SeekInCare
    • SeekInCure
    • SeekInClarity
    • OncoSeek
    • LungCanSeek
    • OncoGate
    • LeukoPrint
    • OncoGraph
    • PanCanSeek
    • SeekInEZ
    • EGFRseek
    • PHLseek
    • SeekInJoy
    • PetCanSeek
  • Publication 
    • Research
    • Others
  • Newsroom
  • Product & Service Inquiry
  • …  
    • Home
    • Technology
    • Products 
      • Products Overview
      • SeekInCare
      • SeekInCure
      • SeekInClarity
      • OncoSeek
      • LungCanSeek
      • OncoGate
      • LeukoPrint
      • OncoGraph
      • PanCanSeek
      • SeekInEZ
      • EGFRseek
      • PHLseek
      • SeekInJoy
      • PetCanSeek
    • Publication 
      • Research
      • Others
    • Newsroom
    • Product & Service Inquiry

SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York

· Media Resources

One Retrospective Cohort, One Prospective Cohort, in Total of ~2,400 Cancer Patients and Non-cancer Individuals Demonstrate the Performance of SeekInCare Test to Detect Multiple Cancer Types and Predict Tissue of Origin of Cancers

The Achievement of 65.5% Sensitivity at 97.9% Specificity in the Retrospective Study and 60.0% Sensitivity at 96.1% Specificity in the Prospective Study Places SeekInCare among the Best-in-Class in Non-invasive Multi-cancer Early Detection

SeekIn Presents Retrospective and Prospective Validation Studies of SeekInCare Multi-omics Multi-cancer Early Detection test at the 20th ICGC Workshop and 7th ARGO Meeting in New York (prnewswire.com)

Previous
Next
 Return to site
Cookie Use
We use cookies to improve browsing experience, security, and data collection. By accepting, you agree to the use of cookies for advertising and analytics. You can change your cookie settings at any time. Learn More
Accept all
Settings
Decline All
Cookie Settings
These cookies enable core functionality such as security, network management, and accessibility. These cookies can’t be switched off.
These cookies help us better understand how visitors interact with our website and help us discover errors.
These cookies allow the website to remember choices you've made to provide enhanced functionality and personalization.
Save